Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Enrolling by invitation · NCT05248659 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Enrolling by invitation | Phase 2 / Phase 3 | 2026-05-05 | NCT05248659 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 26 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CISSS de la Monteregie centre-Centre de recherche Hopital Charles Lemoyne | Greenfield Park | Canada | 1 |
| Clinica Nefrologica, Dialisi e Trapianto, IRCCS Ospedale Policlinico San Martino | Genova | Italy | 1 |
| Radboud Universitair Medisch Centrum | Nijmegen | Netherlands | 3 |
| Tel Aviv University Sackler School of Medicine - Meir Medical Center (MMC) (Meir Hospital) | Kfar Saba | Israel | 1 |
| Universitaetsklinikum Carl Gustav Carus | Dresden | Germany | 1 |
| Vseobecna Fakultni Nemocnice V Praze | Prague | Czechia | 29 |